MicroRNAs as diagnostic and therapeutic tools for Alzheimer’s disease: advances and limitations
Alzheimer’s disease (AD) is the most common age-related, progressive neurodegenerative disease. It is characterized by memory loss and cognitive decline and responsible for most cases of dementia in the elderly. Late-onset or sporadic AD accounts for > 95% of cases, with age at onset > 65 year...
Main Authors: | Bridget Martinez, Philip V Peplow |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2019-01-01
|
Series: | Neural Regeneration Research |
Subjects: | |
Online Access: | http://www.nrronline.org/article.asp?issn=1673-5374;year=2019;volume=14;issue=2;spage=242;epage=255;aulast=Martinez |
Similar Items
-
Cerebrospinal fluid microRNAs as potential biomarkers in Alzheimer’s disease
by: Ahmed Noor Eddin, et al.
Published: (2023-07-01) -
MicroRNAs in Alzheimer’s Disease: Diagnostic Markers or Therapeutic Agents?
by: Francesco Angelucci, et al.
Published: (2019-06-01) -
MicroRNAs in Extracellular Vesicles of Alzheimer’s Disease
by: Wanran Li, et al.
Published: (2023-05-01) -
Circulating microRNAs in Alzheimer’s disease: the search for novel biomarkers
by: Veronique eDorval, et al.
Published: (2013-08-01) -
MicroRNAs as diagnostic markers and therapeutic targets for traumatic brain injury
by: Bridget Martinez, et al.
Published: (2017-01-01)